This archive report was first published on 11 July 2021.
Published on July 11, 2021, the COVID-19 vaccination campaign in Kenya has reached a mere 2% of the adult population, a far cry from the ambitious targets set by President Uhuru Kenyatta.
As of July 11, a total of 1,538,340 vaccines had been administered across the country, with the majority being males at 55%. The uptake of the second dose among those who received their first dose was reported at 49.8%.
The Ministry of Health reported that the second dose uptake by Priority Groups was as follows: Health Workers 97,955, Aged 58 years and above 158,123, Others 144,437, Teachers 70,561, while Security Officers were at 40,444.
President Kenyatta had earlier announced that the government had ordered 13 million doses of the Johnson & Johnson vaccine, which were expected to arrive in the country by August. The second dose of Astrazeneca vaccines were being administered across the country after Kenya received 360,000 additional doses of COVID-19 AstraZeneca vaccine from Denmark in June.
The COVID-19 positivity rate stood at 8.9% as of Saturday, with a fatality toll of 3,721 representing a death rate of 2% since the pandemic was reported in March 2020. The COVID-19 recovery rate stood at 94.4% with a total of 178,119 people having recovered from the virus.
